Across TCGA pan-cancer cohorts, RPS24P14 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS24P14’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPS24P14 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS24P14 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

THCA, LUSC, and BRCA are the cancer types where RPS24P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS24P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.315	<.001	9	view →
LUSC	Male	III,IV	−0.310	.040	2	view →
BRCA	All	III,IV	−0.128	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RPS24P14 RNA expression & survival · all RPS24P14 data types